Clinical trial
The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring…
NCT00275639 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275639 |
|---|---|
| Title | The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant |
| Official title | A Randomized, Double-blinded, Placebo-controlled Study of Angiotensin II Receptor Blockade to Prevent Renal Dysfunction Following Liver Transplantation. |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplant Recipients |
| Intervention type | Drug |
| Interventions | Cozaar |
| Enrollment | 62 |
| Start date | Dec 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Jan 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: